PASTORELLI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 7.328
NA - Nord America 6.966
AS - Asia 6.241
SA - Sud America 778
AF - Africa 152
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.522
Nazione #
US - Stati Uniti d'America 6.763
GB - Regno Unito 2.745
CN - Cina 2.092
SG - Singapore 1.943
IT - Italia 1.336
BR - Brasile 622
DE - Germania 593
SE - Svezia 584
HK - Hong Kong 498
RU - Federazione Russa 489
FR - Francia 361
VN - Vietnam 333
IN - India 293
BD - Bangladesh 222
NL - Olanda 190
IE - Irlanda 188
JP - Giappone 174
FI - Finlandia 172
TR - Turchia 141
CA - Canada 134
ES - Italia 134
ID - Indonesia 132
KR - Corea 115
GR - Grecia 105
UA - Ucraina 105
DK - Danimarca 77
CI - Costa d'Avorio 66
PL - Polonia 55
AR - Argentina 51
MX - Messico 39
AU - Australia 38
UZ - Uzbekistan 35
AT - Austria 29
TW - Taiwan 29
CO - Colombia 28
BE - Belgio 27
PH - Filippine 23
PK - Pakistan 23
CH - Svizzera 22
MY - Malesia 21
NO - Norvegia 21
EC - Ecuador 20
PT - Portogallo 20
EU - Europa 19
ZA - Sudafrica 19
VE - Venezuela 18
RO - Romania 17
SA - Arabia Saudita 17
CZ - Repubblica Ceca 16
IL - Israele 16
AE - Emirati Arabi Uniti 15
CL - Cile 15
IQ - Iraq 15
IR - Iran 15
TH - Thailandia 14
EG - Egitto 11
JO - Giordania 10
KE - Kenya 10
MA - Marocco 10
NP - Nepal 10
NZ - Nuova Zelanda 9
PE - Perù 9
HU - Ungheria 7
AL - Albania 6
LK - Sri Lanka 6
PY - Paraguay 6
RS - Serbia 6
SY - Repubblica araba siriana 6
UY - Uruguay 6
JM - Giamaica 5
LT - Lituania 5
LU - Lussemburgo 5
NG - Nigeria 5
OM - Oman 5
AO - Angola 4
AZ - Azerbaigian 4
CR - Costa Rica 4
GE - Georgia 4
LB - Libano 4
MO - Macao, regione amministrativa speciale della Cina 4
PR - Porto Rico 4
TN - Tunisia 4
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
GT - Guatemala 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
QA - Qatar 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AP - ???statistics.table.value.countryCode.AP??? 2
BB - Barbados 2
BH - Bahrain 2
BZ - Belize 2
FJ - Figi 2
GI - Gibilterra 2
HN - Honduras 2
KW - Kuwait 2
Totale 21.499
Città #
Southend 2.499
Singapore 1.135
Ashburn 769
Dallas 552
Chandler 465
Hong Kong 436
Beijing 381
San Jose 335
Fairfield 330
Milan 330
Seattle 292
Wilmington 242
Council Bluffs 226
Princeton 191
Dublin 187
Woodbridge 173
Los Angeles 155
Hefei 150
Houston 143
New York 143
Frankfurt am Main 132
Cambridge 121
Ann Arbor 120
Santa Clara 114
Lauterbourg 111
Jakarta 110
Bengaluru 108
Dearborn 108
Helsinki 108
Ho Chi Minh City 108
Guangzhou 96
Hanover 87
Nanjing 86
Moscow 84
Rome 84
Shanghai 78
Buffalo 76
Redwood City 76
Des Moines 72
Tokyo 72
Hanoi 71
Abidjan 66
São Paulo 61
Phoenix 53
Chicago 52
Nuremberg 52
Boardman 50
Andover 46
Redmond 46
Berlin 45
Jacksonville 43
Cangzhou 42
The Dalles 42
Columbus 39
Warsaw 39
Madrid 38
Munich 37
Atlanta 36
Toronto 36
Mountain View 35
Turin 35
Chengdu 34
London 34
Istanbul 33
Seoul 32
Shenyang 32
Jinan 30
Shenzhen 27
Tianjin 27
Wuhan 25
Changsha 24
Ottawa 24
Washington 23
Tashkent 22
Amsterdam 21
Hangzhou 21
Athens 20
Birmingham 20
Bologna 20
Denver 19
Nanchang 19
Naples 19
Rio de Janeiro 19
Haiphong 18
San Diego 18
San Francisco 18
Serra 18
Bogotá 17
Brooklyn 16
Saint Petersburg 16
Bitonto 15
Brussels 15
Fuzhou 15
Montreal 15
Paris 15
Silver Spring 15
Stockholm 15
Bari 14
Florence 14
Hyderabad 14
Totale 12.862
Nome #
Contribution of Extracellular Matrix and Signal Mechanotransduction to Epithelial Cell Damage in Inflammatory Bowel Disease Patients: A Proteomic Study 701
Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis 500
Terminal ileum ileoscopy and histology in patients undergoing high-definition colonoscopy with virtual chromoendoscopy for chronic nonbloody diarrhea : a prospective, multicenter study 478
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion 441
Outcomes of COVID-19 in 79 patients with IBD in Italy : an IG-IBD study 428
Small-bowel capsule endoscopy with panoramic view : results of the first multicenter, observational study (with videos) 365
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis 320
Bowel Sonoelastography in Patients with Crohn's Disease : a Systematic Review 294
Hold the Foam : Why Topical Budesonide Remains Relevant for IBD Therapy 292
Major duodenal papilla prolapse in Cronkhite-Canada syndrome 287
Extensive small-bowel Crohn's disease detected by the newly introduced 360° panoramic viewing capsule endoscopy system 284
Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function 273
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 266
Biomarkers and Microscopic Colitis : An Unmet Need in Clinical Practice 252
Editorial : the increasing burden of microscopic colitis 248
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report of a pilot study 241
Aberrant expression of IFI16 in the intestinal epithelia from inflammatory bowel disease is induced by pro-inflammatory cytokines 236
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study 235
Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism 234
The role of IL-33 in gut mucosal inflammation 233
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 231
IL-33 activates tumor stroma to promote intestinal polyposis 230
Severe azathioprine-induced liver injury 22 months after initiation of treatment 229
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis 227
A rare case of angina bullosa hemorrhagica of the esophagus 226
Over-the-scope clip-assisted endoscopic full-thickness resection after incomplete resection of rectal adenocarcinoma 222
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 222
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MmxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report a pilot study 217
A consumer's guide for probiotics : 10 golden rules for a correct use 217
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives 216
Proinflammatory Interleukin-33 Induces Dichotomic Effects on Cell Proliferation in Normal Gastric Epithelium and Gastric Cancer 215
Associations between genetic polymorphism in IL-33, IL1R1 and risk for inflammatory bowel disease 214
Outcome of transfusion-associated chronic hepatitis C depends on patient age at infection 208
Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation : Lessons Learned from Animal Models and Human Genetics 207
Adrenal incidentalomas (AI) in patients with hereditary hemochromatosis (HH) 206
Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? 206
Prevalence of microscopic colitis in subjects undergoing colonoscopy for non-bloody diarrhea : a prospective epidemiological study 206
Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea : a prospective, multicenter study 206
IL-33 triggers early eosinophil-dependent events leading to metaplasia in a chronic model of gastritis-prone mice 204
Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMxTM for the treatment of mild to moderate left-sided ulcerative colitis : preliminary report of a pilot study 203
Efficacy and tolerability of high and low-volume bowel preparation compared : A real-life single-blinded large-population study 203
Interleukin-33 selectively expands interleukin-17 producing CD 11b+ cell population in an experimental model of spontaneus intestinal inflammation 200
In-vivo axial-strain sonoelastography helps distinguish acutely-inflamed from fibrotic terminal ileum strictures in patients with Crohn's disease : preliminary results 200
Corrigendum: Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice (Frontiers in Medicine, (2017), 4, 10.3389/fmed.2017.00054) 197
Microscopic colitis and colorectal neoplastic lesions in patients with chronic non-bloody diarrhea : a prospective multicenter study 196
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 195
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 194
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis : a real-life experience 193
Role, efficacy and safety of budesonide multi-matrix in ulcerative colitis in real life: A study in three Italian third-level centres 192
Hepcidin is a pivotal mediator of infliximab-induced improvement of iron metabolism in inflammatory bowel diseases 191
Prevalence and clinical significance of antibodies anti-IFI 16 in inflammatory bowel diseases 190
Thulium laser in interventional endoscopy : animal and human studies 190
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 184
Ex vivo experimental study on the Thulium laser system : new horizons for interventional endoscopy (with videos) 183
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease 182
MMX® technology and its applications in gastrointestinal diseases 180
Endoscopic full-thickness resection for T1 early rectal cancer : a case series and video report 177
Emerging drugs for the treatment of ulcerative colitis 176
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system 175
Distinct Anti-IFI16 and Anti-GP2 antibodies in inflammatory bowel disease and their variation with infliximab therapy 173
Microscopic colitis and colorectal neoplastic lesions in patients with chronic non-bloody diarrhea : a prospective, Multicenter Study 173
The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study 172
Do antibodies have a role in IBD pathogenesis? 172
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 171
Proteomic insights on the metabolism in inflammatory bowel disease 168
Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis 166
Spontaneous, immune-mediated gastric inflammation in SAMP1/YitFc mice, a model of Crohn's-like gastritis 161
Usefulness of panoramic 344°-viewing in Crohn's disease capsule endoscopy : a proof of concept pilot study with the novel PillCam™ Crohn's system 161
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis 161
Infliximab-Mediated modulation of Hepcidin improves iron metabolism in Inflammatory Bowel Disease 156
Low prevalence of colorectal neoplasia in microscopic colitis : A large prospective multi-center study 156
Dichotomous effects of interleukin-33 on gastric and intestinal epithelial cell proliferation 155
SAMP1/YitFc mouse strain : a spontaneous model of Crohn's disease-like ileitis 154
Over-the-scope clipping in recurrent colonic diverticular bleeding 154
Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy 152
A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis 151
Inflammatory bowel disease (IBD) : biomarkers identification by proteomic approach 151
High prevalence of antibodies anti-interferon-inducible IFI16 protein in inflammatory bowel diseases 147
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 146
Risk factors for inadequate bowel preparation in patients using high- and low-volume cleansing products 145
Constrained multiple instance learning for ulcerative colitis prediction using histological images 144
Advances in endoscopic imaging in ulcerative colitis 144
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 143
Staging esophageal cancer: low EUS accuracy in t2n0 patients 142
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 140
Pro-inflammatory cytokines Induce aberrant interferon-inducible IFI16 protein expression in inflammatory bowel disease epithelium 138
IL-33 drives eosinophil infiltration and pathogenic type 2 helper T-cell immune responses leading to chronic experimental ileitis 138
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 135
PC.1.3: IL-33-dependent induction of intestinal profibrotic gene expression and myofibroblast hypertrophy : potential role in inflammatory-associated gut fibrosis 134
Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group) 133
Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD : A Domino Effect 130
In vitro effect of Interleukin-33 on gastric adenocarcinoma cell line (AGS) and intestinal epithelial cancer cell line (Caco-2) 130
IL-33-dependent induction of intestinal profibrotic gene expression and myofibroblast hypertrophy : potential role in inflammatory-associated gut fibrosis 128
Multidimensional Prognostic Index Predicts Clinical Outcome and Mortality in Hospitalised Older Patients with Diverticular Disease 128
Novel cytokine signaling pathways in inflammatory bowel disease : insight into the dichotomous functions of IL-33 during chronic intestinal inflammation 127
Safety and efficacy of dual emission endoscopic laser treatment in patients with upper or lower gastrointestinal vascular lesions causing chronic anemia: results from the first multicenter cohort study 125
Idea for in vivo differentiation of ulcerative colitis and Crohn's disease with confocal laser endomicroscopy 121
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison study 120
Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy : an IG-IBD study 120
Microscopic Colitis : What Do We Know About Pathogenesis? 116
Totale 20.499
Categoria #
all - tutte 64.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.871


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021462 0 0 0 0 0 0 0 0 0 0 286 176
2021/20222.038 181 165 147 196 166 141 144 133 245 188 63 269
2022/20231.782 190 171 158 186 175 304 50 96 187 67 149 49
2023/20241.407 68 99 90 72 334 93 90 97 37 85 155 187
2024/20253.524 131 324 73 305 278 225 206 322 233 313 427 687
2025/20267.202 813 521 947 625 720 424 665 318 985 525 659 0
Totale 22.354